Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: Mol Pharm. 2016 Jun 27;13(8):2844–2854. doi: 10.1021/acs.molpharmaceut.6b00461

Figure 4.

Figure 4

A) Cumulative release of Cyt c from FA-PEG-PLGA-coated NPs after exposure to various conditions of GHS. B) The capability of Cyt c-based NPs coated with FA-PEG-PLGA-SH to activate caspase-9 and -3, after exposure to the reducing agent glutathione (GHS). This capability is contrasted with native Cyt c and FA-PEG-PLGA-S-S-LA NP (LA= α-lactalbumin). C) Scheme of Cyt c release in the intracellular reducing environment to induce apoptosis.